214 related articles for article (PubMed ID: 2198643)
1. [Physiology of fibrinolysis and thrombolytic agents].
Perego D; Pogliani EM
Recenti Prog Med; 1990 Apr; 81(4):276-81. PubMed ID: 2198643
[TBL] [Abstract][Full Text] [Related]
2. [The fibrinolytic system and its activators].
Seifried E
Z Gesamte Inn Med; 1993; 48(6-7):272-82. PubMed ID: 8333223
[TBL] [Abstract][Full Text] [Related]
3. [Position and developmental trends in fibrinolytic therapy].
Markwardt F
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):6-17. PubMed ID: 2427416
[TBL] [Abstract][Full Text] [Related]
4. [New thrombolytic agents in myocardial infarction].
Charbonnier B; Lang M; Brochier M
Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
[TBL] [Abstract][Full Text] [Related]
5. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
Veremeenko KN; Kizim AI
Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
[TBL] [Abstract][Full Text] [Related]
6. [Laboratory control of fibrinolytic therapy].
Vinazzer H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):30-7. PubMed ID: 2427412
[TBL] [Abstract][Full Text] [Related]
7. [Plasminogen activators as thrombolytic agents in myocardial infarction].
Chamone DA; Massumoto C; Fujimura AY; Pileggi F; Bellotti G
Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(6):288-94. PubMed ID: 2518605
[TBL] [Abstract][Full Text] [Related]
8. An assessment of regional versus systemic thrombolytic treatment of peripheral and coronary artery thrombosis.
Marder VJ; Francis CW
Prog Hemost Thromb; 1984; 7():325-56. PubMed ID: 6241729
[No Abstract] [Full Text] [Related]
9. [Tissue plasminogen activator: mechanism of action and thrombolytic properties].
Páramo JA; Collen D
Sangre (Barc); 1984; 29(4-C):767-73. PubMed ID: 6393389
[No Abstract] [Full Text] [Related]
10. [New thrombolytic drugs].
Kopeć M
Pol Tyg Lek; 1990 Feb 5-12; 45(6-7):127-30. PubMed ID: 2216951
[No Abstract] [Full Text] [Related]
11. Fibrin-specific thrombolytic agents.
Collen D
Schweiz Med Wochenschr; 1987 Nov; 117(46):1791-8. PubMed ID: 3122317
[TBL] [Abstract][Full Text] [Related]
12. [Thrombolytics and their use].
Alessi MC; Juhan-Vague I
Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996
[TBL] [Abstract][Full Text] [Related]
13. Present-day thrombolytic therapy: therapeutic agents--pharmacokinetics and pharmacodynamics.
Bell WR
Rev Cardiovasc Med; 2002; 3 Suppl 2():S34-44. PubMed ID: 12556741
[TBL] [Abstract][Full Text] [Related]
14. [Structure, function and use of fibrinolysis-promoting and inhibiting factors].
Bachmann F
Arzneimittelforschung; 1988 Mar; 38(3A):474-8. PubMed ID: 3134901
[TBL] [Abstract][Full Text] [Related]
15. Intraarterial fibrinolysis: in vitro and prospective clinical evaluation of three thrombolytic agents.
Pilger E; Lammer J; Bertuch H; Steiner H
Radiology; 1986 Dec; 161(3):597-9. PubMed ID: 3786705
[TBL] [Abstract][Full Text] [Related]
16. [Thrombolytic therapy in cerebrovascular disease].
Alvaro LC; Sádaba F
Neurologia; 1993 Mar; 8(3):110-21. PubMed ID: 8448041
[No Abstract] [Full Text] [Related]
17. [Arterial thrombolysis. Review and future prospects].
Marzelle J; Combe S; Gigou F; Samama M
J Mal Vasc; 1988; 13(4):307-16. PubMed ID: 3143794
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
Collen D; Lijnen HR
Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451
[TBL] [Abstract][Full Text] [Related]
19. Problems of thrombolytic therapy.
Neilson RF; Davidson JF
Adverse Drug React Toxicol Rev; 1996 Mar; 15(1):51-64. PubMed ID: 8920633
[No Abstract] [Full Text] [Related]
20. [Intravenous thrombolytic therapy in acute infarct of the myocardium].
Núñez P; Motta J; Arrocha A; Soto V
Rev Med Panama; 1989 Jan; 14(1):16-25. PubMed ID: 2499016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
